wiseowl research - 7.6c buy recommendation, page-3

chookman

Have a look at their presentation on their website and comparison to ISN's timeline, business model and product - very exciting.

We all agree burette is a slow process, but already in Taiwan and soon to be Brazil - majors testing it in US and EUR is a huge sign. Just need to start hurting their bottom line for them to make a move there.

PeriCoach entirely different - all a marketing play just like ISN's device. They got that to a $180M market cap on no FDA or revenue.

Exciting times here, last time WiseOwl covered them it went to 3.4c and only had 1 product - we now have 2 and one in the MHealth market which is massive